Preparatory work to support the risk assessment for peri‐ and postmenopausal women taking food supplements containing isolated isoflavones
2015; European Food Safety Authority; Volume: 12; Issue: 10 Linguagem: Inglês
10.2903/sp.efsa.2015.en-877
ISSN2397-8325
AutoresMariken Tijhuis, Esmée L. Doets, Vera van der Velpen, Marije Vonk Noordegraaf‐Schouten,
Tópico(s)Estrogen and related hormone effects
ResumoEFSA Supporting PublicationsVolume 12, Issue 10 877E External scientific reportOpen Access Preparatory work to support the risk assessment for peri- and postmenopausal women taking food supplements containing isolated isoflavones M Tijhuis, M Tijhuis Pallas health research and consultancy, Conradstraat 18, 3013 AP, Rotterdam, the Netherlands; Wageningen University and Research Centre, P.O. Box 8129, 6700 EV Wageningen, the NetherlandsSearch for more papers by this authorE Doets, E Doets Pallas health research and consultancy, Conradstraat 18, 3013 AP, Rotterdam, the Netherlands; Wageningen University and Research Centre, P.O. Box 8129, 6700 EV Wageningen, the NetherlandsSearch for more papers by this authorV van der Velpen, V van der Velpen Pallas health research and consultancy, Conradstraat 18, 3013 AP, Rotterdam, the Netherlands; Wageningen University and Research Centre, P.O. Box 8129, 6700 EV Wageningen, the NetherlandsSearch for more papers by this authorM Vonk Noordegraaf-Schouten, M Vonk Noordegraaf-Schouten Pallas health research and consultancy, Conradstraat 18, 3013 AP, Rotterdam, the Netherlands; Wageningen University and Research Centre, P.O. Box 8129, 6700 EV Wageningen, the NetherlandsSearch for more papers by this author M Tijhuis, M Tijhuis Pallas health research and consultancy, Conradstraat 18, 3013 AP, Rotterdam, the Netherlands; Wageningen University and Research Centre, P.O. Box 8129, 6700 EV Wageningen, the NetherlandsSearch for more papers by this authorE Doets, E Doets Pallas health research and consultancy, Conradstraat 18, 3013 AP, Rotterdam, the Netherlands; Wageningen University and Research Centre, P.O. Box 8129, 6700 EV Wageningen, the NetherlandsSearch for more papers by this authorV van der Velpen, V van der Velpen Pallas health research and consultancy, Conradstraat 18, 3013 AP, Rotterdam, the Netherlands; Wageningen University and Research Centre, P.O. Box 8129, 6700 EV Wageningen, the NetherlandsSearch for more papers by this authorM Vonk Noordegraaf-Schouten, M Vonk Noordegraaf-Schouten Pallas health research and consultancy, Conradstraat 18, 3013 AP, Rotterdam, the Netherlands; Wageningen University and Research Centre, P.O. Box 8129, 6700 EV Wageningen, the NetherlandsSearch for more papers by this author First published: 21 October 2015 https://doi.org/10.2903/sp.efsa.2015.EN-877Citations: 2 The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European food Safety Published date: 21 October 2015 Question number: EFSA-Q-2013-00839 AboutPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 2011. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf Utian Translational Science Symposium in Chicago, IL (October 2010). Menopause, 18(7), 732– 53. Adaikan, Srilatha and Wheat, 2009. Efficacy of red clover isoflavones in the menopausal rabbit model. 25 Fertil Steril, 92(6), 2008– 13. Aidelsburger, Schauer, Grabein and Wasem, 2012. Alternative methods for the treatment of post-menopausal troubles. GMS Health Technol Assess, 8Doc03. Alekel, Van Loan, Koehler, Hanson, Stewart, Hanson, Kurzer and Peterson, 2010. The soy isoflavones 63 for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women. Am J Clin Nutr, 91(1), 218– 30. Alipour, Afshar, Moini, Dastjerdi, Saberi, Bayani, Eslami and Hosseini, 2012. Clinical and ultrasonographic changes of the breast after use of soy isoflavones. Asian Pac J Cancer Prev, 13(12), 6093– 5. Al-Nakkash, Janjulia, Peterson, Lucy, Wilson, Peterson, Prozialeck and Broderick, 2013. Genistein and exercise do not improve cardiovascular risk factors in the ovariectomized rat. Climacteric, #Volume##Pages#. Alves, Lima, Galvao, Schanaider and Aoki, 2009. Effects of Trifolium pratense and Cimicifuga racemosa in vaginal epithelium of castrated female Wistar rats. Menopause, 16(6), 1242. Andres and Lampen, 2011. Isolates isoflavones are not without risk for women in and after the menopause. Toxicology Letters, 205S264– S264. Andres et al., 2011. Risks and benefits of dietary isoflavones for cancer. Crit Rev Toxicol, 41, 463– 506. Bader, Reitmayer, Arndt, Wober, Kretzschmar, Zierau and Vollmer, 2012. Age dependency of estrogen responsiveness in the uterus and adipose tissue of aromatase-knockout (ArKO) mice. J Steroid Biochem Mol Biol, 128(1-2), 29– 37. Battaglia, Cianciosi, Mancini, Fabbri, Busacchi, Nappi and Venturoli, 2009. Genistein supplements 174 might not induce clitoral modifications in postmenopausal women: a prospective, pilot study. J Sex Med, 6(11), 3132– 8. Bedell et al., 2014 The pros and cons of plant estrogens for menopause. J Steroid Biochem Mol Biol, 13, 225– 236. Bellou, Karali, Bagli, Al-Maharik, Morbidelli, Ziche, Adlercreutz, Murphy and Fotsis, 2012. The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth. Mol Cancer, 1135. Bitto, Altavilla, Bonaiuto, Polito, Minutoli, Di Stefano, Giuliani, Guarini, Arcoraci and Squadrito, 2009. 220 Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome. J Endocrinol, 200(3), 367– 76. Bitto, Granese, Triolo, Villari, Maisano, Giordano, Altavilla, Marini, Adamo, Nicotina, D'Anna and Squadrito, 2010. Genistein aglycone: a new therapeutic approach to reduce endometrial hyperplasia. Phytomedicine, 17(11), 844– 50. Bitto, Polito, Atteritano, Altavilla, Mazzaferro, Marini, Adamo, D'Anna, Granese, Corrado, Russo, 226 Minutoli and Squadrito, 2010. Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab, 95(6), 3067– 72. Bitto, Squadrito, Burnett, Altavilla, Marini and D'Anna, 2010. Genistein aglycone is effective in reducing bone loss and some predictors of cardiovascular risk in postmenopausal women: A 3-years study. Journal of Clinical Densitometry, 13110. Bliedtner, Zierau, Albrecht, Liebhaber and Vollmer, 2010. Effects of genistein and estrogen receptor subtype- specific agonists in ArKO mice following different administration routes. Mol Cell Endocrinol, 314(1), 41– 52. Bolca, Urpi-Sarda, Blondeel, Roche, Vanhaecke, Possemiers, Al-Maharik, Botting, De Keukeleire, Bracke, Heyerick, Manach and Depypere, 2010. Disposition of soy isoflavones in normal human breast tissue. Am J Clin Nutr, 91(4), 976– 84. Boniglia, Concetta; Carratù, Brunella; Gargiulo, Raffaella; Giammarioli, Stefania; Mosca, Maurizio; Sanzini, 2009. Elisabetta. Content of phytoestrogens in soy-based dietary supplements. Food Chemistry, 115(4), 1389– 1392 Boucher, Cotterchio, Curca, Kreiger, Harris, Kirsh, Goodwin, 2012. Intake of phytoestrogen foods and supplements among women recently diagnosed with breast cancer in Ontario, Canada Nutr Cancer, 64(5), 695– 703. Brown, Belles, Lindley, Zimmer-Nechemias, Zhao, Witte, Kim and Setchell, 2010. The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer. Carcinogenesis, 31(5), 886– 93. Bulajic, 2009. Fitoestrogens and breast tightness in menopause women on HRMaturitas, 63S72. Burnett, Bitto, Pillai, Altavilla, Squadrito and Levy, 2010. Pharmacokinetic comparison of fosteum and Citracal(registered trademark)plus bone density builder suggest differences in steady-state concentrations of genistein due to formulation. Menopause, 17(6), 1226. Carbonel, Baracat, Simoes, Simoes, Baracat and Soares, Jr., 2011. The soybean concentrated extract proliferates the vagina of adult rats. Menopause, 18(1), 93– 101. Carbonel, Haidar, Gomes, Simoes, Simoes, Maganhin, Rassi, Baracat and Soares-Jr, 2009. Proliferation histomorphometric and immunohistochemical markers on the ovariectomized rat vagina after estrogen and/or isoflavone treatments. Menopause, 16(6), 1243. Carbonel, Santos, Simoes, Silva, Soares, Jr., Baracat and Haidar, 2011. [Effects of high doses of genistein on mammary gland of female rat]. Rev Bras Ginecol Obstet, 33(9), 264– 9. Carbonel, Simoes, Santos, Baracat, Simoes Mde, Baracat and Soares Junior, 2011. Effects of high-dose 329 isoflavones on rat uterus. Rev Assoc Med Bras, 57(5), 534– 9. Carbonel, Simoes, Simoes, Baracat, Teixeira, Haidar, Dos Santos, Baracat and Soares, 2012. Early and late effects of estrogen or isoflavone on the uterus of castrated rats. Menopause, 19(12), 1379– 1380. Carmignani, Pedro, Costa-Paiva and Pinto-Neto, 2010. The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial. Maturitas, 67(3), 262– 9. Caruso, Falduzzi, Ventura, Rubino, Polizzi, Ferrara, Leo, Grasso and Cianci, 2011. Alternative therapies in the treatment of climacteric symptoms: Efficacy of tibolone vs phytoestrogens. Giornale Italiano di Ostetricia e Ginecologia, 33(5), 279– 282. Cerundolo, Michel, Court, Shrestha, Refsal, Oliver, Biourge and Shofer, 2009. Effects of dietary soy isoflavones on health, steroidogenesis, and thyroid gland function in dogs. Am J Vet Res, 70(3), 353– 60. Chalupka, 2011. Soy isoflavones for the prevention of menopausal symptoms and bone loss–a safe and effective alternative to estrogen?. AAOHN J, 59(11), 504. Chambers, 2009. Influence of diet on metastasis and tumor dormancy. Clinical & Experimental Metastasis, 26(1), 61– 66. Che, Kwon, Kim, You, Kim, Lee, Chung and Kang, 2011. Acute and subchronic toxicity of FCD, a soybean extract combined with L-carnitine, in Sprague-Dawley rats. Regul Toxicol Pharmacol, 59(2), 285– 92. Chen, Hong, Lee and Huang, 2009. The bone-protective effect of a Taiwanese yam (Dioscorea alata cv. 398 Tainung No.2) in ovariectomised female BALB/C mice. Journal of the Science of Food and Agriculture, 89(3), 517– 522. Chen, Zeng, Xin, Huang and Chen, 2011. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Horm Metab Res, 43(10), 681– 6. Chilibeck, Vatanparast, Pierson, Case, Olatunbosun, Whiting, Beck, Pahwa and Biem, 2013. Effect of 438 exercise training combined with isoflavone supplementation on bone and lipids in postmenopausal women: a randomized clinical trial. J Bone Miner Res, 28(4), 780– 93. Cho, Imai, Ito, Takami, Hasumura, Yamazaki, Hirose and Nishikawa, 2009. A 13-week subchronic toxicity study of dietary administered saponin-rich and isoflavones-containing soybean extract in F344 rats. Food Chem Toxicol, 47(8), 2150– 6. Chopra, Frolich and Schrenk, 2010. Isoflavones and L-carnitine: More risk than benefit. Pharmazeutische Zeitung, 155(26), #Pages#. Chung, Chung, Houng, Jeun, Kweon, Choi, Park, Park and Lee, 2009. Toxicological evaluation of the isoflavone puerarin and its glycosides. European Food Research and Technology, 230(1), 145– 153. Cianci, Cicero, Colacurci, Matarazzo and De Leo, 2012. Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women. Gynecol Endocrinol, 28(9), 699– 702. Cianci, Rodolico, Cicero, Colacurci, De Leo and Descovich, 2011. Efficacy and safety clinical evaluation of isoflavones and berberine in combination on vasomotor symptoms and lipid profile in menopausal women. Climacteric, 14120. Cicero, Gerocarni, Grandi and Borghi, 2011. Effects of a combined netraceutical agent on metabolic parameters and biomarkers of vascular remodelling in post-menopausal women. High Blood Pressure and Cardiovascular Prevention, 18(3), 151. Cicero, Tartagni, Ferroni, De Sando, Grandi and Borghi, 2013. Combined nutraceutical approach to postmenopausal syndrome and vascular remodeling biomarkers. J Altern Complement Med, 19(6), 582– 7. Cohen, 2011. Does long-term use of soy isoflavones place women at increased risk for endometrial hyperplasia or endometrial cancer?. Focus on Alternative and Complementary Therapies, 16(2), 147– 148. Colacurci, De Franciscis, Atlante, Mancino, Monti, Volpini and Benvenuti, 2011. Controlled clinical study on long term safety of isoflavones plus lactobacillus sporogenes, vitamin D3 and CA in menopause. Climacteric, 14121. Colacurci, De Franciscis, Atlante, Mancino, Monti, Volpini and Benvenuti, 2013. Endometrial, breast 491 and liver safety of soy isoflavones plus Lactobacillus sporogenes in post-menopausal women. Gynecol Endocrinol, 29(3), 209– 12. Conroy, Maskarinec, Park, Wilkens, Henderson and Kolonel, 2012. The effects of soy consumption before diagnosis on breast cancer survival: The multiethnic cohort study. American Journal of Epidemiology, 175S143. Conroy, Maskarinec, Park, Wilkens, Henderson and Kolonel, 2013. The effects of soy consumption before diagnosis on breast cancer survival: the Multiethnic Cohort Study. Nutr Cancer, 65(4), 527– 37. D'Anna, Cannata, Marini, Atteritano, Cancellieri, Corrado, Triolo, Rizzo, Russo, Gaudio, Frisina, Bitto, 514 Polito, Minutoli, Altavilla, Adamo and Squadrito, 2009. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study. Menopause, 16(2), 301– 6. de la Parra, Otero-Franqui, Martinez-Montemayor and Dharmawardhane, 2012. The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4. J Biol Chem, 287(50), 41640– 50. Delmanto, Nahas-Neto, Traiman, Uemura, Pessoa and Nahas, 2013. Effects of soy isoflavones on mammographic density and breast parenchyma in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial. Menopause, 20(10), 1049– 54. Desmarais and Looper, 2010. Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions. Maturitas, 67(4), 296– 308. Djandjoulia, Batia, Broderick and Al-Nakkash, 2010. Effects Of Genistein And Exercise On Ovariectomized And Intact Rats. Faseb Journal, 24#Pages#. Dominik, Wuttke and Seidlova-Wuttke, 2011. Effects of equol on the uterus and the mammary gland in ovariectomized rats. Can equol become an alternative therapy to classical estrogen replacement in postmenopausal women?. Climacteric, 1460– 61. Dong and Qin, 2011. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat, 125(2), 315– 23. Du, Yang, Hartman, Cooke, Doerge, Ju and Helferich, 2012. Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice. Carcinogenesis, 33(4), 895– 901. Edalati and Bagherzadeh, 2013. Dadizein soy isoflavone and its gut metabolite, equol: A review of animal and human studies. Annals of Nutrition and Metabolism, 63178. Eden, 2012. Phytoestrogens for menopausal symptoms: a review. Maturitas, 72(2), 157– 9. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to soy isoflavones and maintenance of bone mineral density (ID 1655) and reduction of vasomotor symptoms associated with menopause (ID 1654, 1704, 2140, 3093, 3154, 3590) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2012; 10(8):2847. [ 36 pp.]. doi:10.2903/j.efsa.2012.2847. Available online: www.efsa.europa.eu/efsajournal EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to soy isoflavones and protection of DNA, proteins and lipids from oxidative damage (ID 1286, 4245), maintenance of normal blood LDL-cholesterol concentrations (ID 1135, 1704a, 3093a), reduction of vasomotor symptoms associated with menopause (ID 1654, 1704b, 2140, 3093b, 3154, 3590), maintenance of normal skin tonicity (ID 1704a), contribution to normal hair growth (ID 1704a, 4254), “cardiovascular health” (ID 3587), treatment of prostate cancer (ID 3588), and “upper respiratory tract” (ID 3589) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011; 9(7):2264. [ 44 pp.]. doi:10.2903/j.efsa.2011.2264. Available online: www.efsa.europa.eu/efsajournal EFSA Scientific Committee; Guidance on selected default values to be used by the EFSA Scientific Committee. Scientific Panels and Units in the absence of actual measured data. EFSA Journal 2012; 10(3): 2579. Elliott, Evans, Sharma, Berman and Guthrie, 2009. Genistein reduces the number and duration of hot flashes in peri/post menopausal women in a randomized, double-blind, placebo-controlled, multi-center trial. The FASEB Journal, 23(S1), #Pages#. Emilija, 2010. Fitoestrogens and breast tightness in menopause women on HRJournal of Psychosomatic Obstetrics and Gynecology, 31106. Enderlin, Coleman, Stewart and Hakkak, 2009. Dietary soy intake and breast cancer risk. Oncol Nurs Forum, 36(5), 531– 9. Evans, Elliott, Sharma, Berman and Guthrie, 2011. The effect of synthetic genistein on menopause 631 symptom management in healthy postmenopausal women: a multi-center, randomized, placebo-controlled study. Maturitas, 68(2), 189– 96. Fan, Fan, Wang, Mao, Shi, Ibrahim, Ma, Yu, Hou, Wang and Li, 2013. Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway. Stem Cell Research and Therapy, 4(6), #Pages#. Ferrari, 2009. Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. J Obstet Gynaecol Res, 35(6), 1083– 90. Ferrer, 2009. Phytoestrogen, QUO vadis?. Maturitas, 63S23. Fetka, Grach and Fattinger, 2010. Isoflavones and their effects on postmenopausal discomfort with the focus on arteriosclerosis and osteoporosis. Ernahrung, 34(10), 414– 415. Francesco, Annamaria and Angelamaria, 2012. Herbal drugs and food supplements in menopause. European Journal of Integrative Medicine, 451– 52. Francisco, Carbonel, Simoes, Soares, Jr., Baracat and Haidar, 2013. Do extracts of oral soybean 676 augment the trophic effect of estrogen on the rat uterus?. Climacteric, 16(1), 161– 8. Fritz, Seely, Flower, Skidmore, Fernandes, Vadeboncoeur, Kennedy, Cooley, Wong, Sagar, Sabri and Fergusson, 2013. Soy, red clover, and isoflavones and breast cancer: a systematic review. PLoS One, 8(11), e81968. Gaete, Tchernitchin, Bustamante, Villena, Lemus, Gidekel, Cabrera and Astorga, 2012. Daidzein-estrogen interaction in the rat uterus and its effect on human breast cancer cell growth. J Med Food, 15(12), 1081– 90. Geller, Shulman, Van Breemen, Banuvar, Zhou, Epstein, Hedayat, Nikolic, Krause, Piersen, Bolton, 721 Pauli and Farnsworth, 2009. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: A randomized controlled trial. Menopause, 16(6), 1156– 1166. Ghaemi, Soleimanjahi, Razeghi, Gorji, Tabaraei, Moradi, Alizadeh and Vakili, 2012. Genistein induces a protective immunomodulatory effect in a mouse model of cervical cancer. Iran J Immunol, 9(2), 119– 27. Gilani, Farmer, Dyck, Robertson, Dahiya, Sepehr, Fan, Nicolidakis, Curran and Cooke, 2011. Distribution of isoflavones in samples of serum, liver and mammary glands of rats or pigs fed dietary isoflavones. Ann Nutr Metab, 58(3), 171– 80. Gita, Rashmi, Neera and Vaid, 2009. Evaluation of isoflavone rich soy protein supplementation for postmenopausal therapy. Pakistan Journal of Nutrition, 8(7), 1009– 1017. Gleason, Carlsson, Barnet, Meade, Setchell, Atwood, Johnson, Ries and Asthana, 2009. A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women. Age Ageing, 38(1), 86– 93. Guha, Kwan, Quesenberry, Jr., Weltzien, Castillo and Caan, 2009. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat, 118(2), 395– 405. Guttuso, Jr., 2012. Effective and clinically meaningful non-hormonal hot flash therapies. Maturitas, 72(1), 6– 12. Hafez, 2012. Anti-osteoporotic activity of soy total extract and genistein compound in ovariectomized 783 rats. The Journal of American Science, 8(8), 698– 703. Haidar, Carbonel, Silva, Simoes, Baracat, Soares, Simoes and Baracat, 2012. The evalution of different doses of isoflavone on the endometrium of castrated adult rats. Menopause, 19(12), 1380. Hall, Frey and Soares, 2011. Non-hormonal treatment strategies for vasomotor symptoms: A critical review. Drugs, 71(3), 287– 304. Hooper, Madhavan, Tice, Leinster and Cassidy, 2010. Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update, 16(6), 745– 60. Hooper, Ryder, Kurzer, Lampe, Messina, Phipps and Cassidy, 2009. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update, 15(4), 423– 40. Irace, Marini, Bitto, Altavilla, Polito, Adamo, Arcoraci, Minutoli, Di Benedetto, Di Vieste, de Gregorio, Gnasso, Corrao, Licata and Squadrito, 2013. Genistein and endothelial function in postmenopausal women with metabolic syndrome. Eur J Clin Invest, 43(10), 1025– 31. Islam, Punt, Spenkelink, Murk, van Leeuwen, Rietjens, 2014. Conversion of major soy isoflavone glucosides and aglycones in in vitro intestinal models. Mol Nutr Food Res, 58(3), 503– 15. Jackson, Greiwe, Desai and Schwen, 2011. Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor beta-agonist being developed for the treatment of menopausal symptoms. Menopause, 18(2), 185– 93. Jacobs, Wegewitz, Sommerfeld, Grossklaus and Lampen, 2009. Efficacy of isoflavones in relieving vasomotor menopausal symptoms – A systematic review. Mol Nutr Food Res, 53(9), 1084– 97. Jarry, 2009. Risks: Nutritional and toxicological considerations of phytoestrogens. Planta Medica, 75(9), #Pages#. Jenks, Iwashita, Ueno, Onoda, Uchiyama, Kato and Wake, 2011. Evaluation of S-equol on Estrogen Sensitive Tumor Growth in Ovariectomized Athymic Mice Implanted with MCF-7. Journal of Womens Health, 20(3), 489– 489. Jenks, Uchiyama, Iwashita, Nakagawa, Lee, Kostic and Ragland, 2010. Efficacy and safety of natural S-equol supplement in US postmenopausal women. Menopause-the Journal of the North American Menopause Society, 17(6), 1229– 1229. Kakehashi, Tago, Yoshida, Sokuza, Wei, Fukushima and Wanibuchi, 2012. Hormonally active doses 985 of isoflavone aglycones promote mammary and endometrial carcinogenesis and alter the molecular tumor environment in Donryu rats. Toxicol Sci, 126(1), 39– 51. Kang, Jin and Zhang, 2009. Antitumor and antiangiogenic activity of soy phytoestrogen on 7,12- 1008 dimethylbenz[alpha]anthracene-induced mammary tumors following ovariectomy in Sprague-Dawley rats. J Food Sci, 74(7), H237– 42. Kelley and Carroll, 2010. Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women. J Am Pharm Assoc (2003), 50(5), e106– 15. Khan, Chatterton, Michel, Bryk, Lee, Ivancic, Heinz, Zalles, Helenowski, Jovanovic, Franke, Bosland, 1049 Wang, Hansen, Bethke, Dew, Coomes and Bergan, 2012. Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial. Cancer Prev Res (Phila), 5(2), 309– 19. Khan, Michel, Bryk, Chatterton, Ivancic, Zalles, Hansen, Bethke, Jovanovic and Bergan, 2009. A Phase IIb Trial of Soy Isoflavone Supplementation To Decrease Breast Cell Proliferation in High Risk Women. Cancer Research, 69(24), 554S– 554S. Kolodziejczyk-Czepas, 2012. Trifolium species-derived substances and extracts-Biological activity and prospects for medicinal applications. Journal of Ethnopharmacology, 143(1), 14– 23. Kontos, Agbaje, Rymer and Fentiman, 2010. What can be done about hot flushes after treatment for breast cancer?. Climacteric, 13(1), 4– 21. Kumar and Clark, 2005. Clinical Medicine. Elsevier Saunders. Kusnetsova and Uspenskaya, 2009. Clinical experience of treatment of menopausal disorders. Maturitas, 63S80. Labriola, Pratt and Bufi, 2009. ‘Natural’ hormone replacement and breast cancer risk: Evidence for safety and efficacy. ONCOLOGY, 23(7), 639– 641. Lappe, Kunz, Bendik, Prudence, Weber, Recker and Heaney, 2013. Effect of a combination of genistein, 1181 polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study. Eur J Nutr, 52(1), 203– 215. Leclercq and Jacquot, 2014. Interactions of isoflavones and other plant derived estrogens with estrogen receptors for prevention and treatment of breast cancer-considerations concerning related efficacy and safety. J Steroid Biochem Mol Biol, 139237– 44. Legette, Martin, Shahnazari, Lee, Helferich, Qian, Waters, Arabshahi, Barnes, Welch, Bostwick and 1211 Weaver, 2009. Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats. J Nutr, 139(10), 1908– 13. Legette, Prasain, Arabshahi, Barnes and Weaver, 2010. Pharmacokinetics of dietary equol in ovariectomized rats. Faseb Journal, 24#Pages#. L'Esperance, Frenette, Dionne and Dionne, 2013. Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations. Supportive Care in Cancer, 21(5), 1461– 1474. Lethaby, Marjoribanks, Kronenberg, Roberts, Eden and Brown, 2013. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev, 12CD001395. Levis, Strickman-Stein, Ganjei-Azar, Xu, Doerge and Krischer, 2011. Soy isoflavones in the prevention 1221 of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial. Arch Intern Med, 171(15), 1363– 9. Li, Chen, Hardy and Tollefsbol, 2013. Epigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genistein. PLoS One, 8(1), e54369. Li, Liu, Bai, Wang, Sun, Chen and Hui, 2010. Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am J Clin Nutr, 91(2), 480– 6. Li, Meeran, Patel, Chen, Hardy and Tollefsbol, 2013. Epigenetic reactivation of estrogen receptor-alpha (ERalpha) by genistein enhances hormonal therapy sensitivity in ERalpha-negative breast cancer. Mol Cancer, 129. Lien, Hsu, Lo and Chiou, 2009. Supplementary health benefits of soy aglycons of isoflavone by improvement of serum biochemical attributes, enhancement of liver antioxidative capacities and protection of vaginal epithelium of ovariectomized rats. Nutr Metab (Lond), 615. Lima, Saito, Reis, Postigo, Botogoski and Aoki, 2011. The effects of isoflavones derived from Glycine max (L.) Men: and conjugated equine estrogen on the vaginal epithelium and endometrium of postmenopausal women. Menopause, 18(12), 1363. Lima, Saito, Reis, Postigo, Botogoski and Aoki, 2011. The effects of isoflavones derived from Glycine max (L.) Merr. and conjugated equine estrogen on the vaginal epithelium and endometrium of postmenopausal women. Menopause-the Journal of the North American Menopause Society, 18(12), 1363– 1363. Lipovac, Chedraui, Gruenhut, Gocan, Kurz, Neuber and Imhof, 2012. The effect of red clover isoflavone supplementation over
Referência(s)